Premium
Regulation of the expression of the type‐II collagen gene in periosteum‐derived cells by three members of the transforming growth factor–β superfamily
Author(s) -
Ballock R. Tracy,
Heydemann Ahlke,
Izumi Toshihiro,
Reddi A. Hari
Publication year - 1997
Publication title -
journal of orthopaedic research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.041
H-Index - 155
eISSN - 1554-527X
pISSN - 0736-0266
DOI - 10.1002/jor.1100150321
Subject(s) - periosteum , transforming growth factor , bone morphogenetic protein , microbiology and biotechnology , bone morphogenetic protein 2 , bone morphogenetic protein 7 , growth factor , transforming growth factor beta , transforming growth factor, beta 3 , downregulation and upregulation , biology , bone morphogenetic protein 10 , mesenchymal stem cell , chemistry , gene , in vitro , tgf alpha , anatomy , genetics , receptor
Although transforming growth factors‐β and bone morphogenetic proteins are both capable of inducing bone formation in vivo , the target cells of their osteoinductive actions may be different. To evaluate periosteal cells as potential targets of the actions of transforming growth factor–β and bone morphogenetic protein, we investigated the ability of three members of the transforming growth factor–β superfamily to modulate expression of the gene encoding the α1(II) chain of type‐ll collagen in periosteum‐derived cells in Vitro . The results demonstrate that transforming growth factor–β mRNA is expressed by periosteum‐derived cells and that exogenous transforming growth factor–β1 acts to upregulate expression of the gene encoding collagen α1(II). This effect was observed as early as 12 hours after administration of transforming growth factor–β1 but was not observed in response to bone morphogenetic proteins 3 or 4. No synergy was demonstrated between transforming growth factor–β1 and bone morphogenetic protein‐3 in the ability to upregulate expression of the collagen α1(II) gene. These results support the hypothesis that committed periosteal mesenchymal cells are cellular targets of the action of transforming growth factor–β.